A detailed history of Rockline Wealth Management, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Rockline Wealth Management, LLC holds 2,719 shares of LLY stock, worth $2.44 Million. This represents 0.76% of its overall portfolio holdings.

Number of Shares
2,719
Previous 2,540 7.05%
Holding current value
$2.44 Million
Previous $1.98 Billion 24.58%
% of portfolio
0.76%
Previous 0.69%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 01, 2024

BUY
$724.87 - $909.04 $129,751 - $162,718
179 Added 7.05%
2,719 $2.46 Billion
Q1 2024

May 01, 2024

BUY
$592.2 - $792.28 $302,614 - $404,855
511 Added 25.18%
2,540 $1.98 Billion
Q4 2023

Jan 12, 2024

BUY
$525.19 - $619.13 $1.07 Million - $1.26 Million
2,029 New
2,029 $1.18 Billion

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $854B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Rockline Wealth Management, LLC Portfolio

Follow Rockline Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rockline Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rockline Wealth Management, LLC with notifications on news.